Martina Valgiusti

1.8k total citations
55 papers, 896 citations indexed

About

Martina Valgiusti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Martina Valgiusti has authored 55 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 18 papers in Hepatology. Recurrent topics in Martina Valgiusti's work include Colorectal Cancer Treatments and Studies (18 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Lung Cancer Treatments and Mutations (10 papers). Martina Valgiusti is often cited by papers focused on Colorectal Cancer Treatments and Studies (18 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Lung Cancer Treatments and Mutations (10 papers). Martina Valgiusti collaborates with scholars based in Italy, France and South Korea. Martina Valgiusti's co-authors include Paola Ulivi, Alessandro Passardi, Giovanni Luca Frassineti, Matteo Canale, Andrea Casadei‐Gardini, Giorgia Marisi, Emanuela Scarpi, Giorgio Ercolani, Francesco Giuseppe Foschi and Dino Amadori and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Martina Valgiusti

52 papers receiving 884 citations

Peers

Martina Valgiusti

ONCOL

HEPAT

PRM

Koji Miyahara Japan

Celina Ang United States

Kalliopi Andrikou Italy

Elena Ongaro Italy

Adriana Romiti Italy

Jian-Ming Xu China

Ettore D’Argento Italy

May Cho United States

David Liska United States

Koji Miyahara Japan

Martina Valgiusti

309 ×0.7

ONCOL

335 ×1.3

276 ×1.2

HEPAT

184 ×0.8

PRM

275 ×1.4

Citations per year, relative to Martina Valgiusti Martina Valgiusti (= 1×) peers Koji Miyahara

Countries citing papers authored by Martina Valgiusti

Since Specialization

Citations

This map shows the geographic impact of Martina Valgiusti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Valgiusti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Valgiusti more than expected).

Fields of papers citing papers by Martina Valgiusti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Valgiusti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Valgiusti. The network helps show where Martina Valgiusti may publish in the future.

Co-authorship network of co-authors of Martina Valgiusti

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Valgiusti. A scholar is included among the top collaborators of Martina Valgiusti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Valgiusti. Martina Valgiusti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Petracci, Elisabetta, Alessandro Passardi, Annibale Biggeri, et al.. (2024). Baseline and Longitudinal Neutrophil-to-Lymphocyte Ratio as Prognostic Factor for Metastatic Colorectal Cancer: A Secondary Analysis of the ITACa Randomized Trial. JCO Precision Oncology. 8(8). e2300256–e2300256. 1 indexed citations

Passardi, Alessandro, Alessandro Bittoni, Giorgia Marisi, et al.. (2023). Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab. Therapeutic Advances in Medical Oncology. 15. 2656920–2656920. 10 indexed citations

Vannini, Ivan, Tania Rossi, Martina Valgiusti, et al.. (2023). Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value. Molecular Therapy — Methods & Clinical Development. 29. 473–482. 8 indexed citations

Morgagni, Paolo, Leonardo Solaini, Luca Saragoni, et al.. (2022). Conversion Surgery in Gastric Cancer Carcinomatosis. Frontiers in Oncology. 12. 852559–852559. 4 indexed citations

Passardi, Alessandro, Ilario Giovanni Rapposelli, Emanuela Scarpi, et al.. (2021). Multimodal Treatment with GEMOX Plus Helical Tomotherapy in Unresectable Locally Advanced Pancreatic Cancer: A Pooled Analysis of Two Phase 2 Studies. Biomolecules. 11(8). 1200–1200. 3 indexed citations

Rapposelli, Ilario Giovanni, Valentina Zampiga, Ilaria Cangini, et al.. (2021). Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancer. BMC Cancer. 21(1). 611–611. 4 indexed citations

Yoo, Changhoon, Sara Lonardi, Hyung‐Don Kim, et al.. (2021). Sequential Treatment of Sorafenib–Regorafenib Versus Sorafenib–Physician’s Choice: A Propensity Score-Matched Analysis. Targeted Oncology. 16(3). 401–410. 5 indexed citations

Passardi, Alessandro, Emanuela Scarpi, Elisa Neri, et al.. (2019). Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. Cancers. 11(5). 663–663. 9 indexed citations

Casadei‐Gardini, Andrea, Emanuela Scarpi, Paola Ulivi, et al.. (2019). <p>Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study</p>. Cancer Management and Research. Volume 11. 4357–4369. 18 indexed citations

10.

Ulivi, Paola, Matteo Canale, Alessandro Passardi, et al.. (2018). Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer. International Journal of Molecular Sciences. 19(1). 307–307. 62 indexed citations

11.

Casadei‐Gardini, Andrea, Giorgia Marisi, Matteo Canale, et al.. (2018). Radiofrequency Ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival. OncoTargets and Therapy. Volume 11. 6555–6567. 30 indexed citations

12.

Marisi, Giorgia, Emanuela Scarpi, Alessandro Passardi, et al.. (2018). IL-8 and thrombospondin-1 as prognostic markers in patients with metastatic colorectal cancer receiving bevacizumab. Cancer Management and Research. Volume 10. 5659–5666. 10 indexed citations

13.

Franco, Pierfrancesco, Berardino De Bari, Francesca Arcadipane, et al.. (2018). Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study. Radiation Oncology. 13(1). 172–172. 16 indexed citations

14.

Morgagni, Paolo, Leonardo Solaini, Massimo Framarini, et al.. (2018). Conversion surgery for gastric cancer: A cohort study from a western center. International Journal of Surgery. 53. 360–365. 52 indexed citations

15.

Passardi, Alessandro, Matteo Canale, Martina Valgiusti, & Paola Ulivi. (2017). Immune Checkpoints as a Target for Colorectal Cancer Treatment. International Journal of Molecular Sciences. 18(6). 1324–1324. 107 indexed citations

16.

Ulivi, Paola, Emanuela Scarpi, Elisa Chiadini, et al.. (2017). Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy. International Journal of Molecular Sciences. 18(6). 1240–1240. 39 indexed citations

17.

Casadei‐Gardini, Andrea, Flavia Foca, Mario Scartozzi, et al.. (2017). Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study. Scientific Reports. 7(1). 42499–42499. 28 indexed citations

18.

Marisi, Giorgia, Alessandro Passardi, Mario Scartozzi, et al.. (2017). Ang-2 polymorphisms in relation to outcome in advanced HCC patients receiving sorafenib. Annals of Oncology. 28. iii1–iii2. 1 indexed citations

19.

Marisi, Giorgia, Emanuela Scarpi, Alessandro Passardi, et al.. (2017). Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab. Scientific Reports. 7(1). 1293–1293. 24 indexed citations

20.

Casadei‐Gardini, Andrea, Emanuela Scarpi, Luca Faloppi, et al.. (2016). Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib. Oncotarget. 7(41). 67142–67149. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact